Lifeon Pharmaceutical plans to recover investment costs by transferring 2.22% equity in Mainowei
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Lifeon Pharmaceutical announced that its associate company, Nanjing Mainowei Pharmaceutical Technology Co., Ltd. (referred to as "Mainowei"), plans to recover its investment costs and intends to transfer 2.22% of Mainowei's equity, with a proposed transfer price of 22.1837 million yuan
According to the Zhitong Finance APP, Lifeon Pharmaceutical (003020.SZ) announced that its affiliated company, Nanjing Mainowei Pharmaceutical Technology Co., Ltd. (referred to as "Mainowei"), plans to transfer 2.22% of its equity in Mainowei to recover investment costs, with a proposed transfer price of 22.1837 million yuan